Nu-Med Plus, Inc. (NUMD)
USD 0.07
(-10.52%)
USD 0.07
(-10.52%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -120.52 Thousand USD | 33.84% |
| 2022 | -182.16 Thousand USD | 78.3% |
| 2021 | -839.44 Thousand USD | 57.92% |
| 2020 | -1.99 Million USD | -95.67% |
| 2019 | -1.01 Million USD | 12.82% |
| 2018 | -1.16 Million USD | -150.65% |
| 2017 | -466.51 Thousand USD | 61.9% |
| 2016 | -1.22 Million USD | -28.76% |
| 2015 | -951.06 Thousand USD | 17.02% |
| 2014 | -1.14 Million USD | -390.56% |
| 2013 | -233.63 Thousand USD | 9.52% |
| 2012 | -258.22 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -20.58 Thousand USD | 62.81% |
| 2024 Q2 | -16.03 Thousand USD | 22.06% |
| 2023 Q1 | -26.97 Thousand USD | -321.82% |
| 2023 FY | -120.53 Thousand USD | 33.84% |
| 2023 Q3 | -15.14 Thousand USD | 34.36% |
| 2023 Q2 | -23.07 Thousand USD | 14.45% |
| 2023 Q4 | -55.34 Thousand USD | -265.38% |
| 2022 Q1 | -59.65 Thousand USD | 46.9% |
| 2022 FY | -182.16 Thousand USD | 78.3% |
| 2022 Q4 | -6394.00 USD | 88.99% |
| 2022 Q3 | -58.05 Thousand USD | 0.03% |
| 2022 Q2 | -58.07 Thousand USD | 2.65% |
| 2021 Q3 | -118.36 Thousand USD | 53.03% |
| 2021 FY | -839.44 Thousand USD | 57.92% |
| 2021 Q2 | -251.99 Thousand USD | 29.36% |
| 2021 Q1 | -356.74 Thousand USD | 27.37% |
| 2021 Q4 | -112.34 Thousand USD | 5.09% |
| 2020 Q4 | -491.16 Thousand USD | -9.21% |
| 2020 Q2 | -904.44 Thousand USD | -505.74% |
| 2020 Q3 | -449.75 Thousand USD | 50.27% |
| 2020 FY | -1.99 Million USD | -95.67% |
| 2020 Q1 | -149.31 Thousand USD | 27.41% |
| 2019 Q1 | -423.72 Thousand USD | -26.12% |
| 2019 Q3 | -146.21 Thousand USD | 40.02% |
| 2019 FY | -1.01 Million USD | 12.82% |
| 2019 Q4 | -205.7 Thousand USD | -40.69% |
| 2019 Q2 | -243.78 Thousand USD | 42.47% |
| 2018 Q1 | -142.56 Thousand USD | 3.5% |
| 2018 Q4 | -335.96 Thousand USD | 35.65% |
| 2018 Q3 | -522.06 Thousand USD | -209.44% |
| 2018 Q2 | -168.71 Thousand USD | -18.34% |
| 2018 FY | -1.16 Million USD | -150.65% |
| 2017 Q2 | -111.3 Thousand USD | -59.63% |
| 2017 FY | -466.51 Thousand USD | 61.9% |
| 2017 Q3 | -137.74 Thousand USD | -23.76% |
| 2017 Q4 | -147.74 Thousand USD | -7.25% |
| 2017 Q1 | -69.72 Thousand USD | 75.55% |
| 2016 Q1 | -65.66 Thousand USD | 53.01% |
| 2016 FY | -1.22 Million USD | -28.76% |
| 2016 Q4 | -285.14 Thousand USD | 59.02% |
| 2016 Q3 | -695.81 Thousand USD | -290.99% |
| 2016 Q2 | -177.96 Thousand USD | -171.03% |
| 2015 FY | -951.06 Thousand USD | 17.02% |
| 2015 Q4 | -139.72 Thousand USD | 53.94% |
| 2015 Q3 | -303.36 Thousand USD | 22.07% |
| 2015 Q2 | -389.29 Thousand USD | -228.03% |
| 2015 Q1 | -118.67 Thousand USD | 77.6% |
| 2014 Q2 | -198.3 Thousand USD | -10.79% |
| 2014 FY | -1.14 Million USD | -390.56% |
| 2014 Q1 | -178.98 Thousand USD | -468.76% |
| 2014 Q4 | -529.89 Thousand USD | -121.77% |
| 2014 Q3 | -238.93 Thousand USD | -20.49% |
| 2013 Q3 | -87.74 Thousand USD | -158.78% |
| 2013 Q4 | -31.47 Thousand USD | 64.13% |
| 2013 FY | -233.63 Thousand USD | 9.52% |
| 2013 Q1 | -80.51 Thousand USD | 1.47% |
| 2013 Q2 | -33.9 Thousand USD | 57.89% |
| 2012 Q1 | -19.54 Thousand USD | 0.0% |
| 2012 Q2 | -46.25 Thousand USD | -136.67% |
| 2012 Q4 | -81.71 Thousand USD | 26.19% |
| 2012 Q3 | -110.71 Thousand USD | -139.39% |
| 2012 FY | -258.22 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | 56.059% |
| IR-Med Inc. | -4.91 Million USD | 97.546% |
| Polarean Imaging plc | -12.55 Million USD | 99.04% |
| Medical Supply International USA, Inc. | 438.18 Thousand USD | 127.506% |
| Avitar, Inc. | 2.73 Million USD | 104.41% |
| AVITA Medical, Inc. | -40.4 Million USD | 99.702% |
| Manhattan Scientifics, Inc. | -703 Thousand USD | 82.855% |
| Össur hf. | 87.46 Million USD | 100.138% |
| Zecotek Photonics Inc. | -3.65 Million USD | 96.704% |
| QHSLab, Inc. | -240.15 Thousand USD | 49.814% |
| Wellstar International, Inc. | -1.79 Million USD | 93.284% |
| Össur hf. | 87.46 Million USD | 100.138% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 2.08 Million USD | 105.792% |
| Escalon Medical Corp. | -104.47 Thousand USD | -15.362% |
| Aurora Spine Corporation | -446.19 Thousand USD | 72.988% |
| BrainsWay Ltd. | -4.92 Million USD | 97.554% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -9.45 Million USD | 98.726% |
| Hamilton Thorne Ltd. | 277.99 Thousand USD | 143.355% |
| Vivos Inc. | -2.79 Million USD | 95.685% |
| MicroPort Scientific Corporation | -516.16 Million USD | 99.977% |
| Kelyniam Global, Inc. | -239.16 Thousand USD | 49.606% |
| REMSleep Holdings, Inc. | -1.77 Million USD | 93.197% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | 68.191% |
| Nanomix Corporation | -8.43 Million USD | 98.571% |
| Theraclion SA | -3.48 Million USD | 96.538% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -707.02 Thousand USD | 82.953% |
| Positron Corporation | -1.36 Million USD | 91.143% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -2.06 Million USD | 94.163% |
| Lombard Medical, Inc. | -29.33 Million USD | 99.589% |
| ALR Technologies Inc. | -2.94 Million USD | 95.909% |
| Stratec SE | 25.26 Million USD | 100.477% |
| Vycor Medical, Inc. | 40.19 Thousand USD | 399.883% |
| Heart Tronics, Inc. | 14.46 Million USD | 100.834% |
| Perimeter Medical Imaging AI, Inc. | -20.72 Million USD | 99.419% |
| SANUWAVE Health, Inc. | -540 Thousand USD | 77.68% |
| VMS Rehab Systems, Inc. | -68.66 USD | -175440.344% |
| Guided Therapeutics, Inc. | -3.45 Million USD | 96.514% |
| Ingen Technologies, Inc. | -1.61 Million USD | 92.531% |
| Odyssey Group International, Inc. | 14.26 Million USD | 100.845% |
| United American Healthcare Corporation | -67 Thousand USD | -79.89% |
| ECGI Holdings, Inc. | -407.48 Thousand USD | 70.422% |
| Capital Group Holdings, Inc. | -634.68 Thousand USD | 81.01% |
| ADM Tronics Unlimited, Inc. | -601.52 Thousand USD | 79.963% |
| Urologix, Inc. | -6.93 Million USD | 98.261% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.26 Million USD | 90.46% |
| Nexeon MedSystems Inc. | -6.26 Million USD | 98.076% |
| SS Innovations International, Inc. | -20.66 Million USD | 99.417% |
| Qualis Innovations, Inc. | -230.24 Thousand USD | 47.652% |
| Smith & Nephew plc | 425 Million USD | 100.028% |
| NIOX Group Plc | 4.6 Million USD | 102.62% |
| Fuse Medical, Inc. | 383.82 Thousand USD | 131.402% |
| Broncus Holding Corporation | -33.22 Million USD | 99.637% |
| Brain Scientific Inc. | -9.6 Million USD | 98.746% |
| Pressure BioSciences, Inc. | -9.5 Million USD | 98.732% |
| Health Logic Interactive Inc. | -60.69 Thousand USD | -98.563% |